Global Sciatica Treatment Market 2025-2029

Description

List of Tables

The sciatica treatment market is forecasted to grow by USD 3,620.6 mn during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the sciatica treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising awareness about sciatica, growing prevalence of risk factors for sciatica, and regulatory support for pipeline drugs.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	4.4%
CAGR	4.6%
Incremental Value	$3,620.6 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's sciatica treatment market is segmented as below:

By End-user

Hospital
Clinics
Others

By Product

Non-surgical treatment
Surgical treatment

By Route Of Administration

Oral
Injectable
Transdermal

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of clonidine micro pellet epidural injections for sciatica treatment as one of the prime reasons driving the sciatica treatment market growth during the next few years. Also, increasing demand for biologics and regenerative therapies for sciatica treatment and rising awareness of physiotherapy for sciatica treatment will lead to sizable demand in the market.

The report on the sciatica treatment market covers the following areas:

Sciatica Treatment Market sizing
Sciatica Treatment Market forecast
Sciatica Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sciatica treatment market vendors that include Abbott Laboratories, Alkem Laboratories Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Johnson and Johnson Services Inc., Jubilant Pharmova Ltd., Kolon Life Sciences Co. Ltd., Seikagaku Corp., Sun Pharmaceutical Industries Ltd., Teijin Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.. Also, the sciatica treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73640

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Sciatica Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Sciatica Treatment Market 2019 - 2023 ($ million)
5.2 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.3 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI in the global sciatica treatment market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

8.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
8.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
8.3 Hospital - Market size and forecast 2024-2029
- Chart on Hospital - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital - Year-over-year growth 2024-2029 (%)
8.4 Clinics - Market size and forecast 2024-2029
- Chart on Clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Clinics - Year-over-year growth 2024-2029 (%)
8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Product

9.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
9.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
9.3 Non-surgical treatment - Market size and forecast 2024-2029
- Chart on Non-surgical treatment - Market size and forecast 2024-2029 ($ million)
- Data Table on Non-surgical treatment - Market size and forecast 2024-2029 ($ million)
- Chart on Non-surgical treatment - Year-over-year growth 2024-2029 (%)
- Data Table on Non-surgical treatment - Year-over-year growth 2024-2029 (%)
9.4 Surgical treatment - Market size and forecast 2024-2029
- Chart on Surgical treatment - Market size and forecast 2024-2029 ($ million)
- Data Table on Surgical treatment - Market size and forecast 2024-2029 ($ million)
- Chart on Surgical treatment - Year-over-year growth 2024-2029 (%)
- Data Table on Surgical treatment - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.4 Injectable - Market size and forecast 2024-2029
- Chart on Injectable - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
- Chart on Injectable - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable - Year-over-year growth 2024-2029 (%)
10.5 Transdermal - Market size and forecast 2024-2029
- Chart on Transdermal - Market size and forecast 2024-2029 ($ million)
- Data Table on Transdermal - Market size and forecast 2024-2029 ($ million)
- Chart on Transdermal - Year-over-year growth 2024-2029 (%)
- Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Alkem Laboratories Ltd.
- Alkem Laboratories Ltd. - Overview
- Alkem Laboratories Ltd. - Business segments
- Alkem Laboratories Ltd. - Key offerings
- Alkem Laboratories Ltd. - Segment focus
- SWOT
15.6 Amneal Pharmaceuticals Inc.
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
15.7 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
15.8 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
15.9 Hikma Pharmaceuticals Plc
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
15.10 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.11 Jubilant Pharmova Ltd.
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key news
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
- SWOT
15.12 Kolon Life Sciences Co. Ltd.
- Kolon Life Sciences Co. Ltd. - Overview
- Kolon Life Sciences Co. Ltd. - Product / Service
- Kolon Life Sciences Co. Ltd. - Key offerings
- SWOT
15.13 Seikagaku Corp.
- Seikagaku Corp. - Overview
- Seikagaku Corp. - Business segments
- Seikagaku Corp. - Key offerings
- Seikagaku Corp. - Segment focus
- SWOT
15.14 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
15.15 Teijin Ltd.
- Teijin Ltd. - Overview
- Teijin Ltd. - Business segments
- Teijin Ltd. - Key news
- Teijin Ltd. - Key offerings
- Teijin Ltd. - Segment focus
- SWOT
15.16 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
15.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
15.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations